Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tonix Pharma ( (TNXP) ) just unveiled an announcement.
Tonix Pharmaceuticals has submitted a New Drug Application to the FDA for its TNX-102 SL product aimed at treating fibromyalgia, backed by promising data from two controlled studies. This move highlights Tonix’s strategic focus on expanding its market footprint with innovative treatments, although the outcome remains subject to regulatory review and market dynamics.
Learn more about TNXP stock on TipRanks’ Stock Analysis page.